Maternal, gestational and neonatal characteristics and maternal angiogenic factors in normotensive pregnancies

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 143, Issue 1, 2009, Pages 29-33

  Staff, Anne Cathrine ^a,b   Harsem, Nina Kittelsen ^a   Braekke, Kristin ^a   Hyer, Marianne ^c   Hoover, Robert N ^d   Troisi, Rebecca ^d,e  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Angiogenic factors; Antiangiogenic profile; Breast cancer; Preeclampsia; Pregnancy

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; PLACENTAL GROWTH FACTOR; PROTEIN SFLT1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMAN; MATERNAL AGE; NEWBORN CARE; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR;

EID: 60449092591     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2008.11.003     Document Type: Article

References (17)

1. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
2. Tjoa M.L., Levine R.J., and Karumanchi S.A. Angiogenic factors and preeclampsia. Front Biosci 12 (2007) 2395-2402
3. Maynard S.E., Min J.Y., Merchan J., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
4. Levine R.J., Maynard S.E., Qian C., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
5. Venkatesha S., Toporsian M., Lam C., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
6. Levine R.J., Lam C., Qian C., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
7. Baumwell S., and Karumanchi S.A. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 106 (2007) c72-c81
8. Folkman J. The role of angiogenesis in tumor growth. Semin Cancer Biol 3 (1992) 65-71
9. Huppertz B., and Peeters L.L. Vascular biology in implantation and placentation. Angiogenesis 8 (2005) 157-167
10. Vatten L.J., Eskild A., Nilsen T.I., Jeansson S., Jenum P.A., and Staff A.C. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 196 (2007) 239-246
11. Staff A.C., Braekke K., Harsem N.K., Lyberg T., and Holthe M.R. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 122 (2005) 33-39
12. Staff A.C., Braekke K., Johnsen G.M., Karumanchi S.A., and Harsem N.K. Circulating concentrations of soluble endoglin (CD105) in fetal and maternal serum and in amniotic fluid in preeclampsia. Am J Obstet Gynecol 197 (2007) 176
13. Maynard S., Epstein F.H., and Karumanchi S.A. Preeclampsia and angiogenic imbalance. Annu Rev Med 59 (2008) 61-78
14. Troisi R., Brække K., Harsem N., Hyer M., Hoover R.N., and Staff A.C. Blood pressure augmentation and maternal circulating concentrations of angiogenic factors at delivery in preeclamptic and uncomplicated pregnancies. Am J Obstet Gynecol 199 (2008) 653.e1-653.e10
15. Johnsen S.L., Rasmussen S., Wilsgaard T., Sollien R., and Kiserud T. Longitudinal reference ranges for estimated fetal weight. Acta Obstet Gynecol Scand 85 (2006) 286-297
16. Vatten L.J., Eskild A., Nilsen T.I., Jeansson S., Jenum P.A., and Staff A.C. Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am J Obstet Gynecol 96 (2006) 239.e1-239.e6
17. Levine R.J., Qian C., Maynard S.E., Yu K.F., Epstein F.H., and Karumanchi S.A. Serum sFlt1 concentration during preeclampsia and mid trimester blood pressure in healthy nulliparous women. Am J Obstet Gynecol 194 (2006) 1034-1041